The Enterprise Value as of November 2024 (TTM) for Aura Biosciences, Inc. (AURA) is 437.65M

According to Aura Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 437.65M. This represents a change of 13.73% compared to the average of 384.82M of the last 4 quarters.

Aura Biosciences, Inc. (AURA) Historical Enterprise Value (quarterly & annually)

How has AURA Enterprise Value performed in the past?

The mean historical Enterprise Value of Aura Biosciences, Inc. over the last ten years is 341.24M. The current 437.65M Enterprise Value has changed 12.73% with respect to the historical average. Over the past ten years (40 quarters), AURA's Enterprise Value was at its highest in in the March 2022 quarter at 535.15M. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.

Aura Biosciences, Inc. (AURA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Aura Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aura Biosciences, Inc. (AURA) Average Enterprise Value

How has AURA Enterprise Value performed in the past?

The current Enterprise Value of Aura Biosciences, Inc. (AURA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Aura Biosciences, Inc. (AURA) Enterprise Value vs. Peers

How is AURA’s Enterprise Value compared to its peers?

Aura Biosciences, Inc.’s Enterprise Value is greater than Aerovate Therapeutics, Inc. (46.23M), greater than Adagene Inc. (22.22M), greater than Acrivon Therapeutics, Inc. Common Stock (163.47M), greater than Rezolute, Inc. (276.11M), greater than AN2 Therapeutics, Inc. (6.48M), greater than Seer, Inc. (132.17M), less than ORIC Pharmaceuticals, Inc. (635.63M), greater than Anebulo Pharmaceuticals, Inc. (36.46M), less than Cullinan Oncology, Inc. (630.54M), greater than C4 Therapeutics, Inc. (307.45M), less than Crinetics Pharmaceuticals, Inc. (4.93B), greater than ALX Oncology Holdings Inc. (68.10M), less than Immatics N.V. (696.05M), greater than BioAtla, Inc. (20.64M), less than Opthea Limited (514.42M),

Build a custom stock screener for Aura Biosciences, Inc. (AURA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aura Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aura Biosciences, Inc. (AURA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aura Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.